Health Care: Drugs

Alnylam Pharmaceuticals Inc (ALNY: NASDAQ)

$56.48 0.62 | 1.11%
07/24/14 - 12:16 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 47.17M 66.72M 82.76M 100.04M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 47.17M 66.72M 82.76M 100.04M
Selling, General, and Administrative Expenses 27.15M 44.61M 38.28M 37.73M
Research & Development 112.96M 86.57M 99.30M 106.38M
Operating Income before D & A (EBITDA) -92.94M -64.46M -54.82M -44.07M
Depreciation & Amortization 10.23M 9.04M 5.12M 4.94M
Interest Income 1.07M 977.00K 1.20M 2.30M
Other Income - Net -47.00K 16.42M -531.00K 6.40M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -102.15M -125.62M -62.77M -47.94M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -102.15M -125.62M -62.77M -47.94M
Income Taxes -2.70M -10.57M 0.00 514.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -89.22M -106.01M -57.65M -43.52M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -89.22M -106.01M -57.65M -43.52M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -89.22M -106.01M -57.65M -43.52M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-89.22M -41.01M -57.65M -43.52M
Preferred Dividends
Net Income Available To Common -89.22M -106.01M -57.65M -43.52M
Basic EPS from Continuing Ops. -1.45 -2.11 -1.36 -1.04
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.45 -2.11 -1.36 -1.04
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.45 -2.11 -1.36 -1.04
Basic Normalized Net Income/Share -1.45 -0.82 -1.36 -1.04
EPS fr Continuing Ops. -1.45 -2.11 -1.36 -1.04
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.45 -2.11 -1.36 -1.04
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.45 -2.11 -1.36 -1.04
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.45 -0.82 -1.36 -1.04
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ALNY

Latest ALNY Headlines from TheStreet

More Financial News for ALNY

Press Releases for ALNY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter